ctrl K

Price Alert

Bone Biologics Corporatio... (BBLG)

NASDAQ: BBLG · Real-Time Price · USD

2.25

-0.10 (-4.26%)

At close: Aug 15, 2025, 12:15 PM

Bone Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.33M	3.03M	7.54M	6.68M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	n/a	328.84K	579.91K	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	3.86M	3.74M	8.5M	6.68M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a
Total Assets	3.86M	3.74M	8.5M	6.68M
Account Payables	373.04K	360.66K	104.79K	99.91K
Deferred Revenue	n/a	n/a	783.67K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	4.67K	470.74K	1.66M	n/a
Total Current Liabilities	377.71K	831.4K	2.55M	99.91K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Liabilities	377.71K	831.4K	2.55M	99.91K
Total Debt	n/a	n/a	n/a	n/a
Common Stock	2.95K	534.00	15.3K	10.35K
Retained Earnings	-85.02M	-80.91M	-71.96M	-70.48M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	3.48M	2.91M	5.95M	6.58M
Total Investments	n/a	n/a	n/a	n/a